(Q48144821)

9 February 2018

title

Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling (English)

1 reference

9 February 2018

0 references

0 references

Miriam Fishbein

1

1 reference

9 February 2018

Sahar Gov

2

1 reference

9 February 2018

Fadi Assaf

3

1 reference

9 February 2018

Mikhal Gafni

4

1 reference

9 February 2018

Ora Keren

5

1 reference

9 February 2018

Yosef Sarne

6

1 reference

9 February 2018

publication date

22 July 2012

1 reference

9 February 2018

Experimental Brain Research

published in

1 reference

9 February 2018

volume

221

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

437-448

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00221-012-3186-5

exact match

0 references

cites work

Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Chronic use of cannabis and poor neural efficiency in verbal memory ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Does heavy marijuana use impair human cognition and brain function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabis abuse as a risk factor for depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Ischemic preconditioning-induced activation of ERK1/2 in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Hippocampus and remote spatial memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Specific attentional dysfunction in adults following early start of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Ras-ERK Signaling in Behavior: Old Questions and New Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Residual Learning Deficit After Heavy Exposure to Cannabis or Alcohol in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Role of CB2 receptors in neuroprotective effects of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Neurocognitive consequences of marihuana--a comparison with pre-drug performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cerebral preconditioning and ischaemic tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

The multiplicity of action of cannabinoids: implications for treating neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Altered affective response in marijuana smokers: an FMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Control of the cell survival/death decision by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoids and cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Survival kinases in ischemic preconditioning and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Preconditioning and postconditioning: underlying mechanisms and clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Long-term effects of frequent cannabis use on working memory and attention: an fMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

The role of extracellular signal-regulated kinases in the neuroprotection of limb ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Attributes of heavy vs. occasional marijuana smokers in a college population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

cAMP response element-binding protein activation in ligation preconditioning in neonatal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

CREB activation in the rapid, intermediate, and delayed ischemic preconditioning against hypoxic-ischemia in neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Imaging cognitive deficits in drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Executive function deficits in short-term abstinent cannabis users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Isoflurane preconditioning and postconditioning in rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoids and brain injury: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

The facilitating and suppressing effects of delta 9-tetrahydrocannabinol on the rise in intrasynaptosomal Ca2+ concentration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabis use and mental health in young people: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Long-term cannabis use: characteristics of users in an Australian rural area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Modulation of extracellular signal-regulated kinases cascade by chronic delta 9-tetrahydrocannabinol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoids: between neuroprotection and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

The dual neuroprotective-neurotoxic profile of cannabinoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Neurotoxicology of cannabis and THC: A review of chronic exposure studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Differential impairments of selective attention due to frequency and duration of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cognitive functioning of long-term heavy cannabis users seeking treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Residual effects of prolonged cannabis administration on exploration and DRL performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Behavioral effects of prolonged administration of ? 9-Tetrahydrocannabinol in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

THC Prevents MDMA Neurotoxicity in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Psychiatric symptoms in male cannabis users not using other illicit drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

A single low dose of tetrahydrocannabinol induces long-term cognitive deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoid receptors and their role in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

CREB and the formation of long-term memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

Cerebellar white-matter changes in cannabis users with and without schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00221-012-3186-5

A simple role for BDNF in learning and memory?

21 January 2018

1 reference

12 December 2020

Cognitive deterioration associated with the use of different psychoactive substances.

1 reference

12 December 2020

Ischemic "cross" tolerance in hypoxic ischemia of immature rat brain

1 reference

12 December 2020

Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.

1 reference

12 December 2020

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.

1 reference

12 December 2020

Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit

1 reference

12 December 2020

Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures

1 reference

12 December 2020

Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.

1 reference

12 December 2020

Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice

1 reference

12 December 2020

Exogenous anandamide protects rat brain against acute neuronal injury in vivo.

1 reference

12 December 2020

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

1 reference

12 December 2020

10.1007/S00221-012-3186-5

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018